메뉴 건너뛰기




Volumn 84, Issue 18, 2012, Pages 8045-8051

Evaluation of intact mass spectrometry for the quantitative analysis of protein therapeutics

Author keywords

[No Author keywords available]

Indexed keywords

ABSOLUTE INTENSITY; ANALYTES; ANALYTICAL TECHNIQUES; CHARGE STATE; CHEMICAL FINGERPRINT; COMPARATIVE METHODS; DEGRADATION PRODUCTS; INTACT PROTEINS; INTERNAL STANDARDS; MANUFACTURING PROCESS; MODEL SYSTEM; MODIFIED PROTEINS; MULTIPLE CHARGE; PEPTIDE MAPPING; POST-TRANSLATIONAL MODIFICATIONS; PROTEIN SPECIES; PROTEIN THERAPEUTICS; QUALITY ASSESSMENT; RELATIVE RATIOS; STANDARD CURVES; STORAGE CONDITION; THERAPEUTIC DRUGS;

EID: 84866414226     PISSN: 00032700     EISSN: 15206882     Source Type: Journal    
DOI: 10.1021/ac301949j     Document Type: Article
Times cited : (38)

References (18)
  • 17
    • 0003484310 scopus 로고    scopus 로고
    • United States Food and Drug Administration. U.S. Department of Health and Human Services, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), May
    • United States Food and Drug Administration. Guidance for Industry: Bioanalytical Method Validation; U.S. Department of Health and Human Services, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), May 2000; http://www.fda.gov/cder/guidance/index.htm.
    • (2000) Guidance for Industry: Bioanalytical Method Validation


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.